Ideagen On Track to Deliver 12[th] Consecutive Year of Growth
- Robust trading despite pandemic
- Enhanced credit facilities secured
- New Non-Executive Chairman Takes Over
Ideagen Plc, a leading provider of regulatory and compliance software for regulated industries expects to announce its 12th consecutive year of growth when preliminary full year results are declared on or around July 22, 2021.
The pre-close trading update issued to the markets today for the year ended April 30, 2021, shows that the business continued to grow organically and with three key acquisitions during the course of the year. Ideagen’s products are considered crucial in helping businesses operating in highly regulated industries to meet their compliance obligations, especially in areas such as supply chains and sustainability and is the reason the company has continued to do well despite the pandemic.
Ideagen expects to report total revenue up 16% at approximately £65.6m (FY 2020: £56.6m) and adjusted EBITDA up 24% to approximately £22.9m (FY 2020: £18.5m). As a SaaS business the Board considers recurring revenue to be the key measure of success. The ARR book of contracted revenue to be recognised over the coming 12 months increased by 50% during the financial year to approximately £69.3m (30 April 2020: £46.2m on a like for like basis, excluding currency movements1).
Ideagen continued to win new customers during the pandemic, including the World Health Organisation, Baker Tilly, Voyageur, PHI Aviation and Sipchem.
Ben Dorks, CEO of Ideagen, said: “I am pleased to report another strong year for Ideagen. Growth in organic and recurring revenue, in addition to excellent cash generation, reflects Ideagen’s resilience during the pandemic. As a SaaS business, we remain focused on growing recurring revenues and expanding our customer base. We continued to execute our strategy, achieving growth organically and through acquisitions, and I am grateful to our team for their effort this year.”
Confidence in the strategy Ideagen is delivering has also been shown by existing long-term bankers NatWest and new partner Santander, who have extended the company’s total available debt facilities to £100m through a new committed credit facility of £75m, with an approved but uncommitted accordion facility of up to £25m, on enhanced commercial terms.
Also confirmed today is that Richard Longdon has become Chairman of Ideagen in a Non-Executive capacity. He succeeds David Hornsby, who was CEO of Ideagen from 2009 and Executive Chairman from 2018. Richard has had a highly successful career in the technology sector, having spent 33 years with AVEVA Group plc, where he was Chief Executive Officer for 17 years until December 2016.
Dorks commented: “We are excited to welcome Richard as our new Chairman. He brings extensive experience from the technology sector and we look forward to his contribution to the Company in his new role. On behalf of the Board, I would like to express our gratitude to David for his leadership, strategic insight, and guidance. David led Ideagen through a period of significant growth and we wish him all the very best in his future endeavours.”
ENDS
- The April 2021 ARR book of £69.3m comprises of contracted revenue that will be recognised over the coming 12 months. The April 2020 comparative of £46.2m is calculated on a like for like basis at constant currency rates. The Group’s previous ARR calculations (30 April 2020: £48.7m) comprised all contracted annual recurring revenue, valued at prevailing exchange rates. A portion of this revenue was due for recognition beyond a 12-month period, allowing for set up and installation.
For more information contact:
Heather Astbury, heather.astbury@ideagen.com, +447340158049
Ideagen’s software helps companies comply with regulation and manage risk.
Ideagen is a leader in the £3 billion regulatory and compliance software market, serving highly regulated industries such as life sciences, healthcare, banking and finance and insurance. Ideagen has made twenty acquisitions to build its market leadership.
More than 5,700 organisations use Ideagen's software, including nine of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of leading pharmaceutical firms.
Ideagen has a diversified customer base including blue chip, global brands such as Heineken, British Airways, BAE, Aggreko, US Navy, Bank of New York and Johnson Matthey, as well as 250 hospitals across the UK and US.
Ideagen is headquartered in the UK, listed on the London Stock Exchange AIM market (Ticker: IDEA.L), and has key hubs in the UK, EU, US, Middle East and South East Asia. For further information please visit www.ideagen.com.
